STAT News
On Extra Extra, STAT News is grouped with center outlets, a placement drawn from the consensus of independent media-bias raters (AllSides, Ad Fontes Media, and Media Bias/Fact Check) rather than our own opinion. Its reliability rating of A reflects a strong track record of factual, well-sourced reporting. That rating is a guide for weighing what you read here, not a verdict on any single article.
We are currently tracking 8 recent articles from STAT News, published over the past 8 hours. Recurring themes in its latest headlines include Stat, Vaccine, and Canc.
The best way to use this profile is comparatively. Read STAT News's coverage of a story alongside how outlets on other parts of the spectrum handle the same event — the facts usually overlap, but the emphasis, language, and what gets left out often do not. Other center sources we track include BBC News, Al Jazeera, Associated Press, and Reuters.
Recent Articles (8)
STAT+: HHS document offers new clues to Kennedy’s vaccine plans
Kennedy asks for feedback on new vaccine recommendation categories, how shots are tested.
STAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more
Roche's Genentech will invest $750 million to double the size of its existing production facility in Oregon
STAT+: Are cancer patients getting too much drug?
Moderna's stunning surge and drop, AI in scientific writing, and more biotech news from The Readout
Scientists deploy Merck’s Ebola vaccine in DRC
Prostate cancer therapy, Meta glasses in hospital settings, and more health news from Morning Rounds
Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?
Urologic oncologists who treat prostate cancer are split over the benefits of focal therapy compared to traditional surgery or radiation.
Opinion: Lil Nas X’s bipolar diagnosis and the paradox of treatment
We continue to romanticize the symptoms of mental health problems, especially when we talk about achievement.
Opinion: A cure for HIV would be a triumph. But it shouldn’t harm survivors
Long-term survivors deserve to see a cure, not fear the losses it might bring.